UCSF CME: Medical Management of HIV/AIDS and Hepatitis

Register

Login to your account using your email address in order to register.
If this is your first course with UCSF CME, please create a new account.

BrochureexhibitorsSyllabus

agenda
Updated


Overview Objectives Accreditation Course Outline
Chairs Faculty Travel & Lodging Cancellation Policy

Department: Medicine
Course Number: MDM20K02
Activity Start Date: December 12, 2019
Activity End Date: December 14, 2019
Location: Park Central Hotel
San Francisco San Francisco CA
Fees:
  Regular Fee On Site Fee
Physician $895 $970
Allied Health Professional $795 $870
Resident/Fellow $795 $870
UCSF Positive Health Program (CME) $70 $70
 

Overview:

This course provides the active intermediate-to-advanced clinician with a comprehensive review of the science of HIV and infectious hepatitis, as well as updates on the application of HIV, HCV and HBV therapies. For ambitious newer clinicians who want a challenge, we continue offer our New Clinicians’ Track (NCT), which provides five additional lectures; antiretroviral therapy (ART), basic pharmacology, ART resistance, opportunistic infections and IRIS.

The course lecturers are leading clinicians and researchers who are also dedicated to teaching in their areas of expertise. Dr. Diane Havlir will frame the conference in the opening plenary with her keen take on the ‘Top Ten Issues’ in HIV medicine. Dr. Susan Buchbinder will provide the underpinnings of prevention efforts and explore future efforts, followed by Drs. Hyman Scott and Jonathan Volk, who will highlight the clinical expansion and nuances of successful PrEP administration. Days 1 and 3 will be filled with important teachings in regard to effective administration of ART beginning with Dr. Monica Gandhi's talk on the ‘State of the Art of Antiretroviral Use’. A lively debate will follow on controversial ART questions including metabolic and weight complications of ART. Dr. Susan Philip will provide an update on STI’s for 2019 and Dr. Priscilla Hsue rejoins the program to bolster our knowledge base on HIV Cardiology.

Day 2 begins with Dr. Annie Luetkemeyer covering Hepatitis C care and cure, followed by Dr. Danielle Brandman covering the evolving topic of NALFD and NASH. Dr. Jenny Price will address the quandaries in HBV and cirrhosis treatment. All of these talks have case-based formats and address the issues that arise in the care of chronically infected and/or cirrhotic patients and the safe administration of efficacious therapies.

Dr. Toby Mauer will conclude the morning by revisiting the common and evolving dermatological manifestations of HIV. The afternoon opens with Dr. Deborah Cohan updating us on HIV and Reproductive Health followed by Dr. Joel Palefsky who rejoins the program this year to cover anal disease and HIV. Small group sessions will occupy the remainder of Day 2.

On Day 3 we will continue to explore how to manage complications common in HIV medicine, with Dr. Vivek Jain speaking on hyperlipidemia and Dr. Oliver Bacon will build on our STI knowledge base and bring interesting cases from the SF City Clinic and beyond. Dr. Steven Deeks will share the progress we have made toward a cure for HIV/AIDS. Dr. Kathleen (Kat) Grieco will address the evolution of available therapies and strategies in her talk on “Addiction Medicine”.

In the afternoon on Day 3, you'll be able to privately test your antiretroviral knowledge and judgment and compare your clinical choices to those of the master clinicians on our ART panel led by Dr. Oliver Bacon. Dr. Kelly Wentworth will join the faculty this year and cover Endocrinology with a focus on “Diabetes and Osteoporosis and HIV”.

This 3-day conference will provide the breadth and depth of topics necessary to effectively practice in the field of HIV Medicine.

This symposium is offered by the HIV, ID and Global Medicine Division, Zuckerberg San Francisco General Hospital and Trauma Center, Department of Medicine, University of California, San Francisco, and the School of Medicine.

TARGET AUDIENCE
Designed for practicing clinicians; including internists, family practitioners, infectious disease specialists, pharmacists, physician assistants, and nurse practitioners, this 3-day course will focus on the practical issues in the care of patients at all stages of HIV/AIDS and infectious HCV/HBV.

Back To Top


Objectives:

An attendee completing this course will have improved skills and strategies to:

Back To Top


Accreditation:

The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

UCSF designates this live activity for a maximum of 21.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This CME activity meets the requirements under California Assembly Bill 1195, continuing education and cultural and linguistic competency.

Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 CreditsTM issued by organizations accredited by the ACCME.

Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed Credit from AAFP, and AMA Category 1 CreditTM for the PRA for organizations accredited by the ACCME.

Pharmacy: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA Category 1 CreditsTM.

Family Physicians: Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.

American Board of Internal Medicine MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 21.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Post-course evaluation must be completed to earn MOC points. IMPORTANT: Please complete your course evaluation at your earliest convenience and no later than Friday, December 27, 2019 if you need your MOC credit reported to your specialty board by any 2019 deadlines.

Back To Top


Course Outline:

To view full program, please download the brochure (.pdf)

Back To Top


Chairs:

Diane V. Havlir, MD
Professor of Medicine; Chief, HIV, ID and Global Medicine Division;
University of California, San Francisco; Zuckerberg San Francisco General Hospital and Trauma Center

Meg D. Newman, MD, FACP
Senate Emeritus – Medicine; HIV, ID and Global Medicine Division;
Zuckerberg San Francisco General Hospital and Trauma Center

Annie Luetkemeyer, MD
Associate Professor of Medicine; HIV, ID and Global Medicine Division;
Zuckerberg San Francisco General Hospital and Trauma Center

Back To Top


Faculty:

COURSE FACULTY

Oliver M. L. Bacon, MD, MPH
Associate Professor of Medicine

Danielle Brandman
Associate Professor of Medicine
Division of Hepatology and Liver Transplantation

Susan Buchbinder, MD
Director, Bridge HIV Population Health Division,
San Francisco Department of Public Health

Jehan Budak, MD
Acting Assistant Professor of Medicine
Department of Allergy and Infectious Diseases
University of Washington Seattle, WA

A. Asa Clemenzi-allen, MD
Physician Lead, HIV Care, Jail Health Services
San Francisco Department of Public Health
Assistant Professor of Medicine

Susa Coffey, MD
Professor of Medicine

Deborah Cohan, MD, MPH
Associate Professor
Department of Obstetrics, Gynecology, and Reproductive Sciences;
Director, Bay Area Perinatal AIDS Center

Steven Deeks, MD
Professor of Medicine

Monica Gandhi, MD, MPH
Professor of Medicine

Katherine Grieco, DO
Medical Director of HAVEN (Health Assistance InterVention and Education Network)
State of Connecticut

C. Bradley Hare, MD
Director, Infectious Diseases,
Kaiser Permanente, San Francisco, CA

Priscilla Hsue, MD
Professor of Medicine
Division of Cardiology

Vivek Jain, MD, MAS
Associate Professor of Medicine

Harry Lampiris, MD
Professor of Medicine
Chief, Infectious Disease Section
San Francisco VA Medical Center

Carina Marquez, MD, MPH
Assistant Professor of Medicine

Toby A. Maurer, MD
Professor and Chief of Dermatology
Zuckerberg San Francisco General

Joel Palefsky, MD, FRCP(C)
Professor of Medicine
Division of Infectious Diseases

Susan Philip, MD, MPH
Deputy Health Officer
Director, Disease Prevention and
Control Branch, Population Health Division, San Francisco Department of Public Health

Sarah Puryear, MD
UCSF Infectious Diseases Clinical Fellow

Jennifer Price, MD
Associate Professor of Medicine
Division of Hepatology and Liver Transplantation

Parya Saberi, PharmD, MAS
Associate Professor of Medicine
UCSF Center for AIDS Prevention Studies

Jonathan E. Volk, MD, MPH
Infectious Diseases & Internal Medicine
Kaiser Permanente, San Francisco, CA

Kelly Wentworth, MD
Assistant Adjunct Professor
Division of Endocrinology

Lisa G. Winston, MD
Professor of Medicine

Back To Top


Travel & Lodging:

Park Central Hotel San Francisco
50 Third Street
San Francisco CA 94103
Hotel Phone: (415) 974-6400
Reservations: 888-627-8561

ONLINE Reservations

Rates: $269 single/ night
Cut-off Date: November 8, 2019 or once room block is filled

 


UNITED AIRLINES
UCSF has negotiated special fares with United Airlines for our course attendees.
Download Online Booking Instructions (.pdf)

Back To Top


Cancellation Policy:

Cancellations received in writing before December 9, 2019 will be refunded, less a $75 administrative fee. No refunds will be made on cancellations received after that date.

Please email your requests to registration@ocme.ucsf.edu.

Back To Top